Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and Cardiomyopathies

zalcitabine has been researched along with Cardiomyopathies in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balcarek, K; Beauvoit, B; Bonnet, J; Deveaud, C; Kirschner, J; Lebrecht, D; Venhoff, AC; Venhoff, N; Walker, UA1
Colan, SD; Mittleman, MA; Oleske, JM; Patel, K; Seage, GR; Van Dyke, RB1
Domanski, MJ; Egan, D; Follmann, DA; Pizzo, PA; Scalise, PP; Sloas, MM; Tucker, EE1
Fischer, GM; Janaky, T; Kele, Z; Skuta, G; Sumegi, B; Szabo, P; Tozser, J1

Other Studies

4 other study(ies) available for zalcitabine and Cardiomyopathies

ArticleYear
Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
    Journal of acquired immune deficiency syndromes (1999), 2010, Dec-15, Volume: 55, Issue:5

    Topics: Animals; Anti-HIV Agents; Cardiomyopathies; Cardiotoxins; Dietary Supplements; DNA Copy Number Variations; DNA, Mitochondrial; Electron Transport Complex IV; Heart; HIV Infections; Mice; Mice, Inbred BALB C; Mitochondria, Heart; Mutation; Nucleosides; Pyrimidines; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Uridine; Zalcitabine; Zidovudine

2010
The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1.
    AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16

    Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiomyopathies; Cardiotonic Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Digoxin; Female; Follow-Up Studies; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Prenatal Exposure Delayed Effects; Proportional Hazards Models; Prospective Studies; Treatment Outcome; United States; Zalcitabine; Zidovudine

2012
Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus.
    The Journal of pediatrics, 1995, Volume: 127, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Cardiomyopathies; CD4 Lymphocyte Count; Child, Preschool; Didanosine; Dose-Response Relationship, Drug; Echocardiography; Female; Heart; HIV; Humans; Infant; Infant, Newborn; Male; Medical Records; Retrospective Studies; Severity of Illness Index; Zalcitabine; Zidovudine

1995
Molecular mechanism of the short-term cardiotoxicity caused by 2',3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions.
    Biochemical pharmacology, 1999, Dec-15, Volume: 58, Issue:12

    Topics: Adenosine Diphosphate Ribose; Animals; Anti-HIV Agents; Cardiomyopathies; DNA; Electrocardiography; Energy Metabolism; Heart; Heat-Shock Proteins; Mass Spectrometry; Mitochondria; Muscle, Skeletal; Oxidation-Reduction; Rats; Rats, Wistar; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Sequence Analysis; Zalcitabine

1999